S. Korea's Celltrion to start phase 1 test vaccine testing on patients with COVID symptoms
- 4 years ago
셀트리온, 코로나19 치료제 경증환자 대상 임상1상 추가 시행
South Korea's Ministry of Food and Drug Safety has approved a phase one clinical trial on a COVID-19 vaccine being produced by South Korean pharmaceutical company Celltrion.
According to the company,... with the latest approval,... researchers will administer its CT-P59 vaccine to nine patients with mild COVID-19 symptoms.
CT-P90 is a genetically modified antibody treatment that the firm is developing.
It is the first to receive clinical approval in South Korea.
South Korea's Ministry of Food and Drug Safety has approved a phase one clinical trial on a COVID-19 vaccine being produced by South Korean pharmaceutical company Celltrion.
According to the company,... with the latest approval,... researchers will administer its CT-P59 vaccine to nine patients with mild COVID-19 symptoms.
CT-P90 is a genetically modified antibody treatment that the firm is developing.
It is the first to receive clinical approval in South Korea.